Dative develops sophisticated silver based compounds with high antimicrobial effect to treat infected wounds. Hard-to-heal wounds put a huge burden on the health care society today. The main problem is that bacteria infect the wound and thereby inhibit the healing process. Multiresistant bacteria worsen the healing additionally as these cannot be treated with standard antibiotics. Dative’s technology has shown potential to have higher effect against multiresistant strains than substances on the traditional dressings while lowering the silver content.
Dative Research
Dative Research Stories
There are currently no stories published about this venture.
Dative develops sophisticated substances to treat infected wounds.
Henrik Elofsson, Business Developer
Dative Research is an Encubator Portfolio Company from CSE class of 2006.
Dative develops sophisticated substances to treat infected wounds.
Medtech
Lars Öhrström
Vratislav Langer
Morsy A.M
Abu Youssef
Yousry Gohar
Alshima'a A. Massoud
+46 736-59 11 91
Vera Sandbergs Allé 8, Gothenburg
